Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul V Viscuse

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Head & Neck|February 2, 2019
Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case seriesPaul V Viscuse, Katharine Price
Mayo Clinic Proceedings|November 15, 2018
69-Year-Old Woman With Fatigue, Dyspnea, and Lower Extremity PainPaul V Viscuse, Arya B Mohabbat
Circulation|October 26, 2018
Persistent ST-Segment Elevation: A Pandora's BoxPaul V Viscuse, Thomas A Foley, Hector I Michelena
Mayo Clinic Proceedings|February 10, 2019
56-Year-Old Man With Abdominal Pain and DyspneaManuel B Braga Neto, Paul V Viscuse, Karna K Sundsted
Prostate Cancer and Prostatic Diseases|February 11, 2021
Clinical considerations for the management of androgen indifferent prostate cancerJacob E Berchuck, Paul V Viscuse, Himisha Beltran, et al.
Journal of the National Cancer Institute|January 24, 2018
Supplements to Help Prevent Neuropathy During Chemotherapy? A Cautionary TaleKarthik V Giridhar, Paul V Viscuse, Charles L Loprinzi, et al.
European Heart Journal. Case Reports|April 26, 2019
Post-ischaemic exuberant left ventricular mass: thrombus vs. tumour-case reportPaul V Viscuse, David J Bartlett, Thomas A Foley, et al.
Current Opinion in Oncology|May 2, 2017
Integrative medicine in cancer survivorsPaul V Viscuse, Katharine Price, Denise Millstine, et al.
Frontiers in Oncology|August 21, 2019
First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective StudyPaul V Viscuse, Katharine A Price, Joaquin J Garcia, et al.
Current Breast Cancer Reports|December 12, 2017
Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast CancerSomaira Nowsheen, Paul V Viscuse, Ciara C O'Sullivan, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Head & Neck|February 2, 2019
Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case seriesPaul V Viscuse, Katharine Price
Mayo Clinic Proceedings|November 15, 2018
69-Year-Old Woman With Fatigue, Dyspnea, and Lower Extremity PainPaul V Viscuse, Arya B Mohabbat
Circulation|October 26, 2018
Persistent ST-Segment Elevation: A Pandora's BoxPaul V Viscuse, Thomas A Foley, Hector I Michelena
Mayo Clinic Proceedings|February 10, 2019
56-Year-Old Man With Abdominal Pain and DyspneaManuel B Braga Neto, Paul V Viscuse, Karna K Sundsted
Prostate Cancer and Prostatic Diseases|February 11, 2021
Clinical considerations for the management of androgen indifferent prostate cancerJacob E Berchuck, Paul V Viscuse, Himisha Beltran, et al.
Journal of the National Cancer Institute|January 24, 2018
Supplements to Help Prevent Neuropathy During Chemotherapy? A Cautionary TaleKarthik V Giridhar, Paul V Viscuse, Charles L Loprinzi, et al.
European Heart Journal. Case Reports|April 26, 2019
Post-ischaemic exuberant left ventricular mass: thrombus vs. tumour-case reportPaul V Viscuse, David J Bartlett, Thomas A Foley, et al.
Current Opinion in Oncology|May 2, 2017
Integrative medicine in cancer survivorsPaul V Viscuse, Katharine Price, Denise Millstine, et al.
Frontiers in Oncology|August 21, 2019
First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective StudyPaul V Viscuse, Katharine A Price, Joaquin J Garcia, et al.
Current Breast Cancer Reports|December 12, 2017
Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast CancerSomaira Nowsheen, Paul V Viscuse, Ciara C O'Sullivan, et al.
Pageof 2